Australia’s health headlines today span trauma, justice and cautious medical hope. A toddler remains in serious condition after a dog attack that left her with neck injuries, as authorities weigh what should happen to the animal. In the courts, Janai Safar, returned from Syria and facing terrorism-related charges, has been refused bail and will remain in custody in Sydney while proceedings continue, with related cases involving other women still unfolding. There is also a more hopeful note in medical research: Amplia Therapeutics has launched a clinical trial of its investigational drug narmafotinib for ovarian cancer in partnership with ANZGOG, offering a fresh avenue of inquiry in a disease badly in need of better treatment options. Elsewhere, national attention has also been drawn to the Archibald Prize’s rolling coverage, a reminder that public life today is balancing crisis, accountability and culture all at once.